More tools:Markets·Screener·Research·Chat

Alamar Biosciences, Inc. Common Stock (ALMR) Financial Statements

Alamar Biosciences, Inc. Common Stock
SIC 3826 · LABORATORY ANALYTICAL INSTRUMENTS
FIGI BBG012FD22X6
XNAS · usd
29.95▼ 0.85 (-2.76%)
As of 2026-09-08
Valuation
Market Cap
Enterprise Value—
Trailing P/E—
Price / Sales—
EV / Revenue—
EV / EBITDA—
Financial Highlights
Revenue (TTM)—
Net Income (TTM)—
EBITDA—
Diluted EPS (TTM)—
EBITDA Margin—
Net Debt—
Trading Information
Previous Close30.80
Day's Range29.75 – 30.91
52-Week Range18.85 – 38.54
Volume221.4K
Avg Volume312.1K
Share Statistics
Shares Outstanding
Employees—
ExchangeXNAS
Listed2026-04-17
Share count as of July 31, 2026
Loading Income Statement…
Key questions about Alamar Biosciences, Inc. Common Stock (ALMR)
What is Alamar Biosciences, Inc. Common Stock's Market Cap?
Alamar Biosciences, Inc. Common Stock's Market Cap is $2.1B, based on as-reported figures from SEC (XBRL) filings.
Showing the most recent year. Subscribe for full statement history.
Income Statement(in thousands of USD, except per-share data)
Source: Akyla.ai
Line ItemJun 30, 2026Mar 31, 2026Jun 30, 2025Mar 31, 2025
Revenue:
Total revenue
Cost of revenue:
Total cost of revenue
Gross profit
% of revenue60.2%55.5%
Operating expenses:
Research and development
Selling, general and administrative
Total operating expenses
% of revenue106.2%103.0%
Loss from operations
% of revenue-46.0%-47.4%
Interest income, net
Interest expense
Loss on remeasurement of convertible notes
Other (expense) income, net
Net loss before income tax
Net loss
% of revenue-44.9%-81.9%
Net loss per share, basic
Net loss per share, diluted